BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
24 ч
Текуща
Минимум
119.7
Максимум
122.55
Приходи | -142M 667M |
---|---|
Продажби | 152M 5.4B |
P/E Средно за сектора | 26.27 57.333 |
EPS | 2.2 |
Дивидентна доходност | 1.34 |
Марж на печалбата | 12.311 |
EBITDA | 85M 1.6B |
Препоръки | Купи |
---|---|
12-месечна прогноза | +38.83% upside |
Дивидентна доходност Средно за сектора | 1.34% 2.63% |
---|---|
Следващи печалби | 15.05.2025 г. |
Пазарна капитализация | 33B 98B |
---|---|
Предишно отваряне | 119.98 |
Предишно затваряне | 121.4 |
By Trading Central
Увереност
Very Strong Bullish Evidence
117.55 / 120.4 Подкрепа & съпротива
Миналото представяне не гарантира бъдещи резултати.
6.03.2025 г., 06:27 ч. UTC
Merck KGaA Forecasts Earnings, Sales Growth After In-Line Results
DJ
Прочетени
11.02.2025 г., 07:03 ч. UTC
Germany's Merck in Talks to Buy SpringWorks Therapeutics
DJ
Прочетени
10.02.2025 г., 16:38 ч. UTC
SpringWorks Therapeutics Shares Rise on Report it May be Acquired
DJ
Прочетени
24.04.2025 г., 22:51 ч. UTC
Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- Update
DJ
Прочетени
24.04.2025 г., 20:54 ч. UTC
Merck KGaA: No Final Decision Has Been Taken; No Legally Binding Agreement Has Been Entered Into
DJ
Прочетени
24.04.2025 г., 20:50 ч. UTC
Merck KGaA Confirms Late-Stage Discussions With SpringWorks Therapeutics on Potential Acquisition for About 47c a Share
DJ
Прочетени
24.04.2025 г., 19:05 ч. UTC
Merck KGaA Expected to Pay Close to $47 a Share for SpringWorks, Sources Say -- WSJ
DJ
Прочетени
24.04.2025 г., 19:05 ч. UTC
Merck KGaA, SpringWorks Deal Expected to Be Finalized as Soon as Monday, Sources Say -- WSJ
DJ
Прочетени
24.04.2025 г., 19:05 ч. UTC
Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- WSJ
DJ
Прочетени
24.04.2025 г., 19:05 ч. UTC
Merck KGaA Nears Roughly $3.5 Billion Takeover of SpringWorks Therapeutics, Sources Say -- WSJ
DJ
Прочетени
6.03.2025 г., 11:18 ч. UTC
Impact from U.S. Tariffs Is Manageable for Merck KGaA, CEO Says -- Market Talk
DJ
Прочетени
6.03.2025 г., 11:14 ч. UTC
Merck KGaA's Outlook Signals Greater Transparency -- Market Talk
DJ
Прочетени
6.03.2025 г., 08:20 ч. UTC
Merck KGaA's Earnings Guidance Seems Soft Amid Semiconductor Uncertainty -- Market Talk
DJ
Прочетени
6.03.2025 г., 06:00 ч. UTC
Merck KGaA Expects 2025 Net Sales Between EUR21.5B and EUR22.9B
DJ
Прочетени
6.03.2025 г., 06:00 ч. UTC
Merck KGaA 2024 Adj EPS EUR8.63
DJ
Прочетени
6.03.2025 г., 06:00 ч. UTC
Merck KGaA Expects 2025 EBITDA Before One-Time Items Between EUR6.1B and EUR6.6B
DJ
Прочетени
6.03.2025 г., 06:00 ч. UTC
Merck KGaA 2024 EBIT EUR3.645B
DJ
Прочетени
6.03.2025 г., 06:00 ч. UTC
Merck KGaA 2024 After-Tax Profit EUR2.79B
DJ
Прочетени
6.03.2025 г., 06:00 ч. UTC
Merck KGaA 2024 Ebitda Before One-Time Items EUR6.07B
DJ
Прочетени
6.03.2025 г., 06:00 ч. UTC
Merck KGaA 2024 EBITDA EUR5.78B
DJ
Прочетени
6.03.2025 г., 06:00 ч. UTC
Merck KGaA 2024 Sales EUR21.16B
DJ
Прочетени
6.03.2025 г., 06:00 ч. UTC
Merck KGaA Keeps Dividend at EUR2.20
DJ
Прочетени
6.03.2025 г., 06:00 ч. UTC
Analysts Saw Merck KGaA 2024 Sales at EUR21.14B
DJ
Прочетени
6.03.2025 г., 06:00 ч. UTC
Analysts Saw Merck KGaA 2024 Ebitda Before One-Time Items at EUR6.08B
DJ
Прочетени
11.02.2025 г., 16:45 ч. UTC
Merck's Potential Springworks Deal Unlikely to Move Needle on Earnings -- Market Talk
DJ
Прочетени
11.02.2025 г., 10:54 ч. UTC
Germany's Merck Potential Buy of SpringWorks Therapeutics Puts Its Strategy Into Question -- Market Talk
DJ
Прочетени
11.02.2025 г., 10:52 ч. UTC
German Merck's Potential Buy of SpringWorks Therapeutics Holds Profitability Risk -- Market Talk
DJ
Прочетени
6.01.2025 г., 13:08 ч. UTC
Merck KGaA: Transaction closed on Dec. 23, 2024
DJ
Прочетени
6.01.2025 г., 13:07 ч. UTC
Merck KGaA: Didn't Disclose Financial Details
DJ
Прочетени
6.01.2025 г., 13:06 ч. UTC
Merck KGaA: HUB's Organoid Offering Complements Merck KGaA's Cell Culture Portfolio
DJ
Прочетени
Ценова промяна
By TipRanks
12-месечна прогноза
Среден 166.25 EUR 38.83%
Висок 190 EUR
Нисък 107 EUR
Според 9 анализатори от Wall Street, предложили 12-месечна ценова цел за Merck KGaA през последните три месеца.
By TipRanks
Купи
9 ratings
6
Купи
2
Задържане
1
Продай
Според 9 анализатори, дали борсови рейтинги на Merck KGaA през последните 3 месеца.
By Trading Central
Краткосрочен план
Very Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Средносрочен план
Bearish Evidence
All events are bearish.
Дългосрочен план
Bearish Evidence
All events are bearish.
Продажбени и админисративни разходи
Оперативни разходи
Печалба преди облагане с данъци
Продажби
Разходи за продажби
Брутна печалба от продажби
Разходи за лихви по дълг
EBITDA
Оперативна печалба
$